Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH

Genes Chromosomes and Cancer

Volumn 46, Issue 12, 2007, Pages 1119-1128

  Evers, Christina ^a   Beier, Manfred ^a   Poelitz, Anne ^a   Hildebrandt, Barbara ^a   Servan, Kati ^b   Drechsler, Matthias ^a   Germing, Ulrich ^a   Royer, Hans Dieter ^b   Royer Pokora, Brigitte ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW CELL; CHROMOSOME 13Q; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION 13; CHROMOSOME DELETION 5; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ADULT; AGED; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 35348987590     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20498     Document Type: Article

References (44)

1. Albertson DG, Pinkel D. 2003. Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 12:R145-R152.
2. Aul C, Bowen DT, Yoshida Y. 1998. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. Haematologica 83:71-86.
3. Bennett JM. 2000. World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol 72:131-133.
4. Bentz M, Plesch A, Bullinger L, Stilgenbauer S, Ott G, Muller-Hermelink HK, Baudis M, Barth TF, Moller P, Lichter P, Dohner H. 2000. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 27:285-294.
5. Boultwood J, Fidler C, Lewis S, Kelly S, Sheridan H, Littlewood TJ, Buckle VJ, Wainscoat JS. 1994. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: Delineation of the critical region on 5q and identification of a 5q- breakpoint. Genomics 19:425-432.
6. Bullrich F, Veronese ML, Kitada S, Jurlander J, Caligiuri MA, Reed JC, Croce CM. 1996. Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia. Blood 88:3109-3115.
7. Bullrich F, Fujii H, Calin G, Mabuchi H, Negrini M, Pekarsky Y, Rassenti L, Alder H, Reed JC, Keating MJ, Kipps TJ, Croce CM. 2001. Characterization of the 13q14 tumor suppressor locus in CLL: Identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 61:6640-6648.
8. Calin GA, Croce CM. 2006. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance Semin Oncol 33:167-173.
9. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. 2005. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:13944-13949.
10. Corcoran MM, Rasool O, Liu Y, Iyengar A, Grander D, Ibbotson RE, Merup M, Wu X, Brodyansky V, Gardiner AC, Juliusson G, Chapman RM, Ivanova G, Tiller M, Gahrton G, Yankovsky N, Zabarovsky E, Oscier DG, Einhorn S. 1998. Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood 91:1382-1390.
11. Crescenzi B, La Starza R, Romoli S, Beacci D, Matteucci C, Barba G, Aventin A, Marynen P, Ciolli S, Nozzoli C, Martelli MF, Mecucci C. 2004. Submicroscopic deletions in 5q- associated malignancies. Haematologica 89:281-285.
12. Elnenaci MO, Hamoudi RA, Swansbury J, Gruszka-Westwood AM, Brito-Babapulle V, Matutes E, Catovsky D. 2003. Delineation of the minimal region of loss at 13q14 in multiple myeloma. Genes Chromosomes Cancer 36:99-106.
13. Fairman J, Chumakov I, Chinault AC, Nowell PC, Nagarajan L. 1995. Physical mapping of the minimal region of loss in 5q- chromosome. Proc Natl Acad Sci USA 92:7406-7410.
14. Fenaux P. 2001. Chromosome and molecular abnormalities in myelodysplastic syndromes. Int J Hematol 73:429-437.
15. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, Gorman P, Tomlinson IP, Carter NP. 2003. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36:361-374.
16. Germing U, Gattermann N, Strupp C, Aivado M, Aul C. 2000. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: A retrospective analysis of 1600 patients. Leuk Res 24:983-992.
17. Giagounidis AA, Germing U, Haase S, Hildebrandt B, Schlegelberger B, Schoch C, Wilkens L, Heinsch M, Willems H, Aivado M, Aul C. 2004, Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31. Leukemia 18:113-119.
18. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. 1997. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088.
19. Haase D, Fonatsch C, Freund M, Wormann B, Bodenstein H, Bartels H, Stollmann-Gibbels B, Lengfelder E. 1995. Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol 70:171-187.
20. Haase D, Steidl C, Schanz J, Schabla R, Pfeilstocker M, Nosslinger T, Hildebrandt B, Kuendgen A, Lubbert M, Kunzmann B, Giagounidis A, Auls C, Trumper L, Krieger O, Fonatsch C, Valent P, Stauder R, Germing U. 2005. Correlation of cytogenetic findings with morphology, clinical course and prognosis in 2124 patients with MDS. Blood 106:232A.
21. Heim S, Mitelman F, editors. 1995. Cancer Cytogenetics, 2nd ed. New York: Wiley.
22. Horrigan SK, Westbrook CA, Kim AH, Banerjee M, Stock W, Larson RA. 1996. Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood 88:2665-2670.
23. Hosoya N, Sanada M, Nannya Y, Nakazaki K, Wang L, Hangaishi A, Kurokawa M, Chiba S, Ogawa S. 2006. Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization. Genes Chromosomes Cancer 45:482-494.
24. Hupe P, Stransky N, Thiery JP, Radvanyi F, Barillot E. 2004. Analysis of array CGH data: From signal ratio to gain and loss of DNA regions. Bioinformatics 20:3413-3422.
25. ISCN. 1995. An International System for Human Cytogenetic Nomenclature. Mitelman F, editor. Basel: S. Karger.
26. Jaffe E, Harris N, Stein H, Vardiman J. 2001. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Haematopoetic and Lymphoid Tissues. Lyon, France: IARC Press.
27. Janssen JW, Buschle M, Layton M, Drexler HG, Lyons J, van den Berghe H, Heimpel H, Kubanek B, Kleihauer E, Mufti GJ. 1989. Clonal analysis of myelodysplastic syndromes: Evidence of multipotent stem cell origin. Blood 73:248-254.
28. Karnan S, Tsuzuki S, Kiyoi H, Tagawa H, Ueda R, Seto M, Naoe T. 2006. Genomewide array-based comparative genomic hybridization analysis of acute promyelocyte leukemia. Genes Chromosomes Cancer 45:420-425.
29. Ketterling RP, Wyatt WA, VanWier SA, Law M, Hodnefield JM, Hanson CA, Dewald GW. 2002. Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH. Leuk Res 26:235-240.
30. Liu TX, Becker MW, Jelinek J, Wu WS, Deng M, Mikhalkevich N, Hsu K, Bloomfield CD, Srone RM, DeAngelo DJ, Galinsky IA, Issa JP, Clarke MF, Look AT. 2007. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. Nat Med 13:78-83.
31. Mehes G. 2005. Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia. Pathol Oncol Res 11:205-210.
32. Mertens D, Wolf S, Schroeter P, Schaffner C, Dohner H, Stilgenbauer S, Lichter P. 2002. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 99:4116-4121.
33. Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P. 1993. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report on 408 cases. Leukemia 7:1315-1323.
34. Nimer SD. 2006. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q. J Clin Oncol 24:2576-2582.
35. Paulsson K, Heidenblad M, Strombeck B, Staaf J, Jonsson G, Borg A, Fioretos T, Johansson B. 2006. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia 20:840-846.
36. Rondeau G, Moreau I, Bezieau S, Petit JL, Heilig R, Fernandez S, Pennarun E, Myers JS, Batzer MA, Moisan JP, Devilder MC. 2001. Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppresser gene locus. Mutat Res 458:55-70.
37. Royer-Pokora B, Ragg S, Heckl-Ostreicher B, Held M, Loos U, Call K, Glaser T, Housman D, Saunders G, Zabel B, Williams B, Poustka A. 1991. Direct pulsed field gel electrophoresis of Wilms' tumors shows that DNA deletions in 11p13 are rare. Genes Chromosomes Cancer 3:89-100.
38. Sole F, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Luno E, Prieto F, Granada I, Hernandez JM, Cigudosa JC, Diez JL, Bureo E, Marques ML, Arranz E, Rios R, Martinez Climent JA, Vallespi T, Florensa L, Woessner S. 2000. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperative Espanol de Citogenetica Hematologica. Br J Haematol 108:346-356.
39. Stewart B, Verdugo M, Guthrie KA, Appelbaum F, Deeg HJ. 2003. Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes. Br J Haematol 123:879-885.
40. Stilgenbauer S, Nickolenko J, Wilhelm J, Wolf S, Weitz S, Dohner K, Boehm T, Dohner H, Lichter P. 1998. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 16:1891-1897.
41. Trost D, Hildebrandt B, Muller N, Germing U, Royer-Pokora B. 2004. Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics. Leuk Res 28:171-177.
42. Trost D, Hildebrandt B, Beier M, Muller N, Germing U, Royer-Pokora B. 2006. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia. Cancer Genet Cytogenet 165:51-63.
43. Wolf S, Mertens D, Schaffner C, Korz C, Dohner H, Stilgenbauer S, Lichter P. 2001. B-cell neoplasia associated gene with multiple splicing (BCMS): The candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet 10:1275-1285.
44. Zhao N, Stoffel A, Wang PW, Eisenbart JD, Espinosa R, III, Larson RA, Le Beau MM. 1997. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proc Natl Acad Sci USA 94:6948-6953.